A new initiative for Neuroimmunology Australia in 2020 has been the introduction of a webinar series, co-ordinated by A/Prof Markus Hofer.

Each one hour webinar consists of two presentations, which commence at 12 noon (QLD) / 1 pm NSW/VIC/TAS summertime / 10 am (WA) / 02:00 (UTC).

To receive notifications and zoom links to upcoming webinars, or if you would like to participate as a speaker, please contact A/Prof Markus Hofer. Alternatively, click on the highlighted date below for the zoom link for that day (the link differs from meeting to meeting).

Please join us for our 1st Anniversary special webinar -
Thursday 9th September 2021 at 4pm

Speaker 1: David Baker (Queen Mary University of London, UK)
Title: GloBodies in neuroimmunological disease
Summary: Due to treatment failures and concern about anti-drug antibodies, we developed the GloBody platform. This based on the production of a labelled-antibody drug-related VH/VL immunoglobulin chains that complex with anti-drug antibodies. These are captured and measured.  Furthermore, we have rapidly developed this to detect anti-viral infection and vaccination responses in COVID-19 using remote sampling. We have moved this from immunological idea to patient benefit in a number of conditions, notably multiple sclerosis.

Speaker 2: David Hunt (University of Edinburgh, UK)
Title: Type I interferon in brain health and disease
Summary: The type I interferon proteins play a critical role in defending the brain against viral infection, yet interferon can also act as a neurotoxin. This is exemplified by the monogenic type I cerebral interferonopathies such has Aicardi-Gouti√®res Syndrome where very high intracerebral interferon-alpha in infants is associated with severe diffuse brain disease. Type I interferon proteins can play a pathogenic role in some autoimmune disease such as lupus, yet recombinant therapies are effective therapies for diseases such as multiple sclerosis. In this talk I will explore the complex roles type I interferons play in brain disease.

Webinar Schedule - first half of 2021
Friday 26 February

Pattama Songkhunawej (PhD student, USyd) - An important role for pS-STAT1 signalling in an IL-6 driven cytokinopathy
Angelo Lopez (PhD student, USyd) - Validation of a flow cytometry live cell-based assay to detect MOG antibodies for clinical diagnostics

Friday 26 March

Prof V. Wee Yong (University of Calgary, Canada) - Microglia: friends going rogue in neuropathology
Prof Georges Grau (USyd) - Extracellular vesicles in the immunopathogenesis of cerebral malaria

Friday 30 April

A/Prof Gila Moalem-Taylor (UNSW) - Sex-specific transcriptome of spinal microglia in neuropathic pain due to peripheral nerve injury
Dr Jonatan Leffler (Telethonkids/UWA) - The impact of phototherapy on B cell function in early MS

Friday 28 May

Prof Prue Hart (Telethonkids/UWA) - Multiple sclerosis and serum free fatty acids
Dr Eduardo Albornoz (UQ) - Pheripheral innate immune contributions to Parkinson's disease

Friday 25 June

Dr Jacqui Orian (La Trobe) - Platelet targeting vs immunomodulation for the treatment of neuroinflammation: platelet targeting takes the lead
Dr Jana Vukovic (UQ) - The role of repopulating microglia following traumatic brain injury

Friday 30 July

Prof Tomas Kalincik (UMelb) - Rare diseases from data to evidence
Dr Sudarshini Ramanathan (USyd) - Neuropathic pain associated with LGI1 and CASPR2 autoantibodies: clinical and biological comparisons

Special Webinar - Friday 27 August

Brooke Wanrooy (Monash) - Characterising the roles of innate cells in post-stroke neuroinflammation (15 min + 3 min questions)
Nuzhat Tabussum (LaTrobe) - Platelets as killers of neurons in Multiple Sclerosis (10 min + 2 min questions)
Ellen Gillespie (UQ) - Dissecting the acute inflammatory response to spinal cord injury (10 min + 2 min questions)
Jacquie Orian (LaTrobe) - The specific targeting of reactive platelets in neuroinflammation is neuroprotective (10 min + 2 min questions)

Recordings of previous webinars

Thanks to all of our presenters who have agreed to make their presentations available online.

Prof Trevor Kilpatrick

Clinical Director of the Florey Institute of Neuroscience and Mental Health, and Professor of Neurology, the University of Melbourne
Title: Exploring how the innate immune system influences CNS myelination and demyelinating disease
Presentation date: 28 August 2020

Dr Fiona Tea

Fiona has recently been awarded her PhD at the University of Sydney
Title: Utility of MOG antibody epitopes to predict a relapsing course in demyelinating disorders.
Presentation date: 28 August 2020

Dr Nicola Warren

Dr Warren is a Neuropsychiatrist at the Princess Alexandra Hospital in Brisbane. She has recently completed her PhD looking at features of anti-NMDAR encephalitis and how to differentiate it from primary psychiatric disorders.
Title: Anti-NMDAR encephalitis and psychiatry
Presentation date: 25 September 2020

A/Prof Laura Piccio

School of Medical Sciences, Faculty of Medicine and Health, The University of Sydney
Title: TREM2 activation on microglia promotes myelin debris clearance and remyelination in a MS model
Presentation date: 27 November 2020

Pattama Songkhunawej

Pat is currently a final year PhD student at the University of Sydney in the group of Markus Hofer
Title: An important role for pS-STAT1 signalling in an IL-6 driven cytokinopathy
Presentation date: 26 February 2021

Angelo Lopez

Angelo is currently a final year PhD student at the University of Sydney in the group of Fabienne Brilot
Title: Validation of a flow cytometry live cell-based assay to detect MOG antibodies for clinical diagnostics
Presentation date: 26 February 2021

Prof V. Wee Yong

Professor, Hotchkiss Brain Institute, University of Calgary, Canada and
Canada Research Chair in Neuroimmunology
Follow of the Canadian Academy of Health Sciences and the Royal Society of Canada, Former president of the International Society of Neuroimmunology
Title: Microglia: friends going rogue in neuropathology
Presentation date: 26 March 2021


© Copyright Neuroimmunology Australia